TLR signaling in the gut in health and disease

Maria T. Abreu, Masayuki Fukata, Moshe Arditi

Research output: Contribution to journalShort surveypeer-review

515 Scopus citations


The human intestine has evolved in the presence of diverse enteric microflora. TLRs convert the recognition of pathogen-associated molecules in the gut into signals for antimicrobial peptide expression, barrier fortification, and proliferation of epithelial cells. Healing of injured intestinal epithelium and clearance of intramucosal bacteria require the presence of intact TLR signaling. Nucleotide oligomerization domain (Nod)1 and Nod2 are additional pattern recognition receptors that are required for defense against invasive enteric pathogens. Through spatial and functional localization of TLR and Nod molecules, the normal gut maintains a state of controlled inflammation. By contrast, patients with inflammatory bowel disease demonstrate inflammation in response to the normal flora. A subset of these patients carry polymorphisms in TLR and CARD15/NOD2 genes. A better understanding of the delicate regulation of TLR and Nod molecules in the gut may lead to improved treatment for enteric infections and idiopathic inflammatory bowel diseases.

Original languageEnglish
Pages (from-to)4453-4460
Number of pages8
JournalJournal of Immunology
Issue number8
StatePublished - 15 Apr 2005


Dive into the research topics of 'TLR signaling in the gut in health and disease'. Together they form a unique fingerprint.

Cite this